Cosmax, Inc. (192820.KS)
Seongnam-si, KR
Cosmax, Inc. operates as a global entity engaged in the research, development, manufacturing, and distribution of a broad spectrum of goods, including cosmetic items, nutritional supplements, and pharmaceutical products. Its comprehensive beauty product line features skincare formulations, decorative makeup, hair care essentials, and specialty treatments such as facial masks and under-eye patches. Beyond its cosmetic offerings, the company also develops and produces medical equipment and supplies, provides raw materials for cosmetic formulations, and manufactures advanced containers and filling packaging for cosmetics. Originally established as Miroto Korea, the company rebranded to Cosmax, Inc. in 1994. Founded in 1992, its primary corporate offices are located in Hwaseong, South Korea.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.80% | -6.46% | -17.48% | -8.58% | +4.64% | -2.42% | -17.29% | +117.13% | +37.31% | +13.72% | +163.98% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 8 | +3 |
| Buy | 14 | -1 |
| Hold | 4 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Household & Personal Products: +3.3%+10.7% ★ Q1'26: +15.9% (vs Q1'25)
-
EPS growth Household & Personal Products: +8.8%+43.4% ★ Q1'26: +411.3% (vs Q1'25)
-
FCF margin FCF growth · Household & Personal Products: +44.8%+1.5% Q1'26: +3.0% (vs Q1'25)
-
EBIT margin Household & Personal Products: +9.9%+8.2% Q1'26: +7.8% (vs Q1'25)
-
ROIC Household & Personal Products: +8.2%+13.5% ★ Q1'26: +13.5% (vs Q1'25)
-
Share dilution Household & Personal Products: +0.2%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×3.06× Q1'26: 3.41× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 19 Rev. Ana. 19 EPS Ana. |
Dec 2027 24 Rev. Ana. 24 EPS Ana. |
Dec 2028 11 Rev. Ana. 12 EPS Ana. |
Dec 2029 23 Rev. Ana. 22 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
533.34B
est: 535.08B (-0.3%)
|
756.96B
est: 751.42B (+0.7%)
|
883.95B
est: 884.21B (0.0%)
|
1.26T
est: 1.26T (+0.0%)
|
1.33T
est: 1.33T (+0.2%)
|
1.38T
est: 1.39T (-0.5%)
|
1.59T
est: 1.59T (+0.0%)
|
1.60T
est: 1.59T (+0.7%)
|
1.78T
est: 1.78T (-0.2%)
|
2.17T
est: 2.16T (+0.2%)
|
2.40T
est: 2.40T (-0.1%)
|
2.74T
2.69T – 2.81T
+14.2% YoY
|
3.06T
2.70T – 3.28T
+11.7% YoY
|
3.30T
3.06T – 3.46T
+7.7% YoY
|
4.56T
4.23T – 4.79T
+38.3% YoY
|
| EBITDA |
44.31B
est: 43.84B (+1.1%)
|
65.89B
est: 61.56B (+7.0%)
|
54.83B
est: 72.44B (-24.3%)
|
80.02B
est: 103.16B (-22.4%)
|
96.62B
est: 108.81B (-11.2%)
|
66.55B
est: 113.91B (-41.6%)
|
147.49B
est: 130.37B (+13.1%)
|
86.04B
est: 130.15B (-33.9%)
|
175.77B
est: 145.98B (+20.4%)
|
251.67B
est: 204.92B (+22.8%)
|
269.72B
est: 227.50B (+18.6%)
|
259.89B
254.62B – 265.98B
+14.2% YoY
|
290.23B
255.72B – 311.08B
+11.7% YoY
|
312.69B
290.17B – 327.96B
+7.7% YoY
|
432.54B
401.38B – 453.66B
+38.3% YoY
|
| EBIT |
35.18B
est: 25.93B (+35.7%)
|
53.37B
est: 36.41B (+46.6%)
|
34.59B
est: 42.84B (-19.3%)
|
54.74B
est: 61.01B (-10.3%)
|
58.62B
est: 64.35B (-8.9%)
|
20.85B
est: 67.36B (-69.0%)
|
95.81B
est: 77.10B (+24.3%)
|
27.37B
est: 76.97B (-64.4%)
|
116.34B
est: 86.33B (+34.8%)
|
182.98B
est: 133.50B (+37.1%)
|
195.78B
est: 148.21B (+32.1%)
|
169.31B
165.88B – 173.28B
+14.2% YoY
|
189.08B
166.60B – 202.67B
+11.7% YoY
|
203.71B
189.04B – 213.66B
+7.7% YoY
|
281.79B
261.49B – 295.55B
+38.3% YoY
|
| Net Income |
21.24B
est: 27.17B (-21.8%)
|
34.78B
est: 39.17B (-11.2%)
|
18.86B
est: 20.61B (-8.5%)
|
32.62B
est: 32.12B (+1.6%)
|
18.32B
est: 33.47B (-45.3%)
|
-29.05B
est: -20.75B (-40.0%)
|
34.34B
est: 75.09B (-54.3%)
|
-16.45B
est: 45.55B (-136.1%)
|
57.14B
est: 57.89B (-1.3%)
|
85.80B
est: 84.63B (+1.4%)
|
123.06B
est: 110.05B (+11.8%)
|
137.58B
124.70B – 158.71B
+25.0% YoY
|
164.31B
118.31B – 203.22B
+19.4% YoY
|
199.71B
181.01B – 212.39B
+21.5% YoY
|
—
— – —
-100.0% YoY
|
| SGA |
29.17B
est: 24.11B (+21.0%)
|
36.55B
est: 33.86B (+8.0%)
|
43.20B
est: 39.84B (+8.4%)
|
55.93B
est: 56.74B (-1.4%)
|
60.23B
est: 59.85B (+0.6%)
|
70.59B
est: 62.65B (+12.7%)
|
64.60B
est: 71.71B (-9.9%)
|
67.13B
est: 71.58B (-6.2%)
|
69.86B
est: 80.29B (-13.0%)
|
113.52B
est: 110.91B (+2.4%)
|
197.34B
est: 123.14B (+60.3%)
|
140.66B
137.81B – 143.96B
+14.2% YoY
|
157.09B
138.41B – 168.37B
+11.7% YoY
|
169.24B
157.05B – 177.51B
+7.7% YoY
|
234.11B
217.25B – 245.54B
+38.3% YoY
|
| EPS |
2,271.51
est: 2,395.11 (-5.2%)
|
3,787.82
est: 3,452.06 (+9.7%)
|
1,844.29
est: 1,816.86 (+1.5%)
|
3,190.60
est: 2,831.22 (+12.7%)
|
1,791.79
est: 2,950.27 (-39.3%)
|
-2,841.84
est: -1,828.82 (-55.4%)
|
3,203.38
est: 6,618.62 (-51.6%)
|
-1,449.61
est: 4,014.73 (-136.1%)
|
5,036.04
est: 5,102.60 (-1.3%)
|
7,562.96
est: 7,456.03 (+1.4%)
|
10,846.00
est: 9,695.83 (+11.9%)
|
12,121.40
10,987.19 – 13,983.49
+25.0% YoY
|
14,477.02
10,424.16 – 17,904.59
+19.4% YoY
|
17,595.32
15,947.73 – 18,712.39
+21.5% YoY
|
—
— – —
-100.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B | 3/5 | 2/5 | 5/5 | 4/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-28 | B | 3/5 | 2/5 | 5/5 | 4/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-27 | B | 3/5 | 2/5 | 5/5 | 4/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-26 | B | 3/5 | 2/5 | 5/5 | 4/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-22 | B | 3/5 | 2/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-21 | B | 3/5 | 2/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-20 | B | 3/5 | 2/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-19 | B | 3/5 | 2/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-18 | B | 3/5 | 2/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-15 | B | 3/5 | 2/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-14 | B | 3/5 | 2/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-13 | B | 3/5 | 2/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-12 | B | 3/5 | 2/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-11 | B | 3/5 | 2/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-08 | B | 3/5 | 2/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-07 | B | 3/5 | 2/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-06 | B | 3/5 | 2/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-04 | B | 3/5 | 2/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-30 | B | 3/5 | 2/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-29 | B | 3/5 | 2/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-28 | B | 3/5 | 2/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-27 | B+ | 3/5 | 2/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-24 | B+ | 3/5 | 2/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-23 | B+ | 3/5 | 2/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-22 | B+ | 3/5 | 2/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-21 | B+ | 3/5 | 2/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 2/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 2/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 2/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-15 | B+ | 3/5 | 2/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-14 | B+ | 3/5 | 2/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kyung-Soo Lee | Founder & Chairman | 1B | male |
| Choi Kyung | Vice Chairman & President | 542M | male |
| Jaecheon Kim | Vice Chairman & Chief Executive Officer | — | male |
| Sung-Ki Moon | Vice Chairman & Chief Executive Officer of Cosmax BTI | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 192820.KS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
